86120 studies found for:    United States
Show Display Options
Rank Status Study
1 Enrolling by invitation Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Condition: Cognition Disorders
2 Recruiting A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care
Conditions: Pain;   Chronic Pain;   Mental Disorders;   Cardiovascular Diseases;   Diabetes Mellitus, Type 2;   Arthritis
Interventions: Other: Unblinded to Genetic Testing Results;   Other: Blinded to Genetic Testing Results
3 Not yet recruiting Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in COPD Patients
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: QVA149;   Drug: Umeclidinium/vilanterol;   Drug: Placebo (umeclidinium/vilanterol );   Drug: Placebo (QVA149)
4 Not yet recruiting Efficacy and Safety Study of QVA149 in COPD Patients
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: QVA149;   Drug: Umeclidinium/vilanterol;   Drug: Placebo (umeclidinium/vilanterol);   Drug: Placebo (QVA149)
5 Recruiting Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Atezolizumab (MPDL3280A);   Other: Best Supportive Care (BSC)
6 Recruiting Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management
Conditions: Pain;   Chronic Pain;   Back Pain;   Nociceptive Pain;   Neuropathic Pain;   Musculoskeletal Pain;   Neck Pain;   Pain, Intractable
Intervention: Other: Observational
7 Recruiting AVENUE: A Proof-of-Concept Study of RG7716 in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
Condition: Macular Degeneration, Choroidal Neovascularization
Interventions: Drug: RG7716;   Drug: Ranibizumab
8 Recruiting A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults
Condition: Chronic Idiopathic Constipation
Interventions: Drug: BLI400 Laxative;   Drug: Lubiprostone
9 Not yet recruiting Treatment Alternatives in iSGS (NoAAC PR-02 Study)
Condition: Idiopathic Subglottic Stenosis (iSGS)
Interventions: Procedure: Endoscopic dilation of subglottic stenosis;   Procedure: Endoscopic resection of the stenosis;   Procedure: Tracheal Resection
10 Not yet recruiting Growth and Tolerance of Cow's Milk-Based Infant Formulas
Condition: Growth
Interventions: Other: Previously marketed infant formula;   Other: Previously marketed formula using a similar protein
11 Available Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Daratumumab
12 Not yet recruiting Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU
Condition: Chronic Spontaneous Urticaria
Interventions: Biological: QGE031;   Biological: Omalizumab;   Biological: Placebo
13 Not yet recruiting A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT)
Condition: Cystic Fibrosis
Intervention: Other: Observational
14 Recruiting PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation
Conditions: Aortoiliac Aneurysms;   Iliac Aneurysms
Intervention: Device: Zenith® Branch Endovascular Graft-Iliac Bifurcation,
15 Recruiting Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Condition: Malignant Neoplasm
Intervention: Other: Cytology Specimen Collection Procedure
16 Not yet recruiting Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC
Condition: HIV-1 Infection
Interventions: Drug: F/TAF;   Drug: ABC/3TC;   Drug: ABC/3TC Placebo;   Drug: F/TAF Placebo;   Drug: Third antiretroviral agent
17 Active, not recruiting Technology and Design Innovation for School Lunch
Condition: Childhood Obesity
Interventions: Behavioral: SmartMeal application;   Behavioral: Distributed points of sale;   Behavioral: Staff wellness curriculum
18 Recruiting Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)
Condition: Attention-Deficit Hyperactivity Disorder (ADHD)
Interventions: Drug: SHP465;   Drug: Placebo
19 Recruiting Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos)
Condition: COPD
Interventions: Drug: BGF MDI 320/14.4/9.6 μg;   Drug: GFF MDI 14.4/9.6 μg;   Drug: BGF MDI 160/14.4/9.6 μg;   Drug: BFF MDI 320/9.6 μg
20 Not yet recruiting Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: semaglutide;   Drug: liraglutide;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years